On Oct 25, 2021 Cedilla Therapeutics closed a Series B round and raised $25,000,000 from Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock Ventures, Woodline Partners, featuring lead investors RA Capital Management.
About the company: Cedilla Therapeutics is located at United States, North America.
“”
Company website: http://www.cedillatx.com